$1.6 Billion Microcarrier Market - Global Forecast to 2023 with Thermo Fisher Scientific, Merck and GE Healthcare Dominating the Market - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 19, 2018--The “Microcarrier Market by Equipment (Bioreactor, Culture Vessels, Cell Counter, Filtration System), Consumables (Sera, Serum Free Media), Microcarriers (Cationic, Collagen, Protein coated), Application (Vaccines, Cell Therapy) - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The microcarriers market is projected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%.
Growth in this market is driven by the rising demand for cell-based vaccines, technological advancements, and the availability of public and private funding for cell-based research. On the other hand, factors such as the high cost of cell biology research and limitations in the production of high-density cell culture are likely to hinder market growth.
The market in this report is segmented by product, application, end user, and region. Based on product, the market is segmented into equipment and consumables. In 2017, the consumables segment accounted for the largest share of the market owing to the continuous consumption of various media and reagents for different culture processes and applications.
Based on application, the market is segmented into vaccine manufacturing, cell therapy, and other applications. The vaccine manufacturing segment accounted for the largest share of the market, by application, in 2017. The large share of this segment can be attributed to the high and growing demand for cell-based vaccines.
Based on end user, the market is segmented into pharmaceutical and biotechnology companies research institutes, and CROs. In 2017, the pharmaceutical and biotechnology companies segment accounted for the largest share of the microcarriers market. The dominant share of this segment can be attributed to the growing use of single-use technologies in vaccine production, increasing demand for cell-based vaccines, widening application areas of microcarriers, and increasing pharmaceutical R&D expenditure.
In 2017, Europe dominated the global microcarriers market. Growth in this market can mainly be attributed to factors such as the increasing incidence of cancer, growing number of venture capital investments, availability of technologically advanced products, and strategic expansion of biopharmaceutical companies in this region. However, the RoW is expected to register the highest CAGR in the forecast period.
In 2017, Thermo Fisher Scientific (US), Merck KGaA (Germany), and GE Healthcare (US) dominated the market. Other prominent players in this market include Danaher Corporation (US), Corning Incorporated (US), Lonza (Switzerland), Becton, Dickinson and Company (US), Eppendorf AG (Germany), HiMedia Laboratories (India), and Sartorius AG (Germany).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Microcarriers Market Overview
4.2 APAC: Microcarriers Consumables Market, by Type & Country (2017)
4.3 Market, by Region (USD Million)
4.4 Microcarriers: Developing vs Developed Markets, 2018 Vs. 2023 (USD Million)
4.5 Geographical Snapshot of the Market
5 Microcarriers Market, by Product
5.2.2 Culture Vessels
5.2.3 Cell Counters
5.2.4 Filtration Systems
220.127.116.11 Sera/Serum-Based Media
18.104.22.168 Serum-Free Media
22.214.171.124 Other Media
5.3.3 Microcarrier Beads
126.96.36.199 Untreated Microcarrier Beads
188.8.131.52 Cationic Microcarriers
184.108.40.206 Collagen-Coated Microcarriers
220.127.116.11 Protein-Coated Microcarriers
6 Microcarriers Market, by Application
6.2 Vaccine Manufacturing
6.3 Cell Therapy
6.4 Other Applications
7 Microcarriers Market, by End User
7.2 Pharmaceutical & Biotechnology Companies
7.3 Research Institutes
7.4 Contract Research Organizations
8 Microcarriers Market, by Region
8.2 North America
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.4 Rest of Asia Pacific
8.5 Rest of the World (RoW)
9 Competitive Landscape
9.2 Market Share Analysis, 2017
9.3 Competitive Scenario
9.3.1 Partnerships, Agreements, and Collaborations (2015-2018)
9.3.2 Product Launches (2015-2018)
9.3.3 Expansions (2015-2018)
9.3.4 Acquisitions (2015-2018)
10 Company ProfilesBecton, Dickinson and Company Corning Danaher Corporation Eppendorf GE Healthcare (A Subsidiary of General Electric Company) Hi-Media Laboratories Lonza Group AG Merck KGaA Sartorius AG Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/kc69g5/1_6_billion?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005681/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/19/2018 01:02 PM/DISC: 11/19/2018 01:02 PM